Abstract
The potential role of oxygen-derived free radicals in the pathogenesis of neuropsychiatric diseases has been thoroughly discussed in the past few years1, 2, 3. The neurotoxic consequences of superoxide anion, hydrogen peroxide and hydroxyl radical formation have been described, as well as their relevance to abnormal conditions of the central nervous system, such as hyperoxia, hemorrhage, trauma, and aging. A separate line of investigation over the last ten years has established that excessive release of the excitatory neurotransmitter glutamate and sustained activation of glutamate receptors may also be responsible for neuronal degeneration associated with epilepsy, cerebral ischemia, hypoglycemia and other neurodegenerative diseases4, 5, 6. It is now emerging that free radical formation and glutamate receptor activation may act in concert, cooperating in the genesis and propagation of neuronal damage7, 8, 9. The goal of this report is to examine the potential relationship between these two pathogenic events in neurological disease, with particular stress on mechanisms underlying post-ischemic brain damage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H.A. Kontos, Oxygen radicals in CNS damage, Chem.-Biol. Interact. 72:229 (1989).
J.B. Lohr, Oxygen radicals and neuropsychiatric illness. Some speculations, Arch. Gen. Psychiatry 48:1097 (1991).
C.W. Olanow, A radical hypothesis for neurodegeneration, Trends Neurosci. 16:439 (1993).
S.M. Rothman and J.W. Olney, Excitotoxicity and the NMDA receptor, Trends Neurosci. 10:299 (1987).
D.W. Choi, Glutamate neurotoxicity and diseases of the nervous system, Neuron 1:623 (1988).
B. Meldrum and J. Garthwaite, Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci. 11:379 (1990).
S.C. Bondy and C.P. LeBel, The relationship between excitotoxicity and oxidative stress in the central nervous system, Free Radical Biol. Med. 14:633 (1993).
J.T. Coyle and P. Puttfarcken, Oxidative stress, glutamate and neurodegenerative disorders, Science 262:689 (1993).
G.J. Lees, Contributory mechanisms in the causation of neurodegenerative disorders, Neuroscience 54:287 (1993).
H.B. Demopoulos, E.S. Flamm, D.D. Pietronigro, and M.L. Seligman, The free radical pathology and the microcirculation in the major central nervous system disorders, Acta Physiol. Scand. Suppl. 492:91 (1980).
B. Halliwell, Reactive oxygen species and the central nervous system, J. Neurochem. 59:1609 (1992).
J.P. Kehrer, Free radicals as mediators of tissue injury and disease, Crit. Rev. Toxicol. 23:21 (1993).
F. Fonnum, Glutamate: a neurotransmitter in mammalian brain, J. Neurochem. 42:1 (1984).
G.L. Collingridge and R.A.J. Lester, Excitatory amino acid receptors in the vertebrate central nervous system, Pharmacol. Rev. 40:143 (1989).
D.T. Monaghan, R.J. Bridges, and C.W. Cotman, The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system, Ann. Rev. Pharmacol. Toxicol 29:365 (1989).
D. Nicholls and D. Attwell, The release and uptake of excitatory amino acids, Trends Pharmacol. Sci. 11:462 (1990).
J.W. Olney, Excitotoxins: an overview, in: “Excitotoxins,” K. Fuxe, P. Roberts, and R. Schwarcz, ed., Macmillan, London (1983).
D.D. Schoepp and P.J. Conn, Metabotropic glutamate receptors in brain function and pathology, Trends Pharmacol. Sci. 14:13 (1993).
G.P. Gasic and M. Hollmann, Molecular neurobiology of glutamate receptors, Ann. Rev. Physiol. 54:507 (1992).
S. Nakanishi, Molecular diversity of glutamate receptors and implications for brain function, Science 258:597 (1992).
B. Sommer and P.H. Seeburg, Glutamate receptor channels: novel properties and new clones, Trends Pharmacol. Sci. 13:291 (1992).
J.A. Dykens, A. Stern, and E. Trenkner, Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury, J. Neurochem. 49:1222 (1987).
R.J. Miller, Metabotropic excitatory amino acid receptors reveal their true colors, Trends Pharmacol. Sci. 12:365 (1991).
A. Dumuis, M. Sebben, L. Haynes, J.-P. Pin, and J. Bockaert, NMDA receptors activate the arachidonic acid cascade system in striatal neurons, Nature 336:68 (1988).
M. Lafon-Cazal, S. Pietri, M. Culcasi, and J. Bockaert, NMDA-dependent superoxide production and neurotoxicity, Nature 364:535 (1993).
H. Monyer, M. Hartley, and D.W. Choi, 21-Aminosteroids attenuate exitotoxic neuronal injury in cortical cell cultures, Neuron 5:121 (1990).
V.L. Dawson, T.M. Dawson, E.D. London, D.S. Bredt, and S.H. Snyder, Nitric oxide mediates glutamate neurotoxicity in primary cortical neurons, Proc. Natl. Acad. Sci. USA 88:6368 (1991).
D.E. Pellegrini-Giampietro, G. Cherici, M. Alesiani, V. Carlà, and F. Moroni, Excitatory amino acid release from rat hippocampal slices as a consequence of free radical formation, J. Neurochem. 51:1960 (1988).
D.E. Pellegrini-Giampietro, G. Cherici, M. Alesiani, V. Carlà, and F. Moroni, Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage, J. Neurosci. 10:1035 (1990).
B. Barbour, M. Szatkowski, N. Ingledew, and D. Attwell, Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells, Nature 342:918 (1989).
A. Volterra, D. Trotti, P. Cassutti, C. Tromba, A. Salvaggio, R.C. Melcangi, and G. Racagni, High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes, J. Neurochem. 59:600 (1992).
P. Jenner, Oxidative stress as a cause of Parkinson’s disease, Acta Neurol. Scand. 84(suppl. 136): 6 (1991).
J.D. Adams and I.N. Odunze, Biochemical mechanisms of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity, Biochem. Pharmacol. 41:1099 (1991).
K.F. Tipton and T.P. Singer, Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds, J. Neurochem. 61:1191 (1993).
S. Przedborski, V. Kostic, V. Jackson-Lewis, et al., Transgenic mice with increased Cu/Znsuperoxide dismutase activity are resistant to N-methyl-4-phenyl-l,2,3,6-tetrahydropyridineinduced neurotoxicity, J. Neurosci. 12:1658 (1992).
L. Turski, K. Bressler, K.-J. Rettig, P.-A. Loschmann, and H. Wachtel, Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists, Nature 349:414 (1991).
T. Klockgether, L. Turski, T. Honoré, Z. Zhang, D.M. Gash, R. Kurlan, and J.T. Greenamyre, The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys, Ann. Neurol. 30:717 (1991).
P.S. Spencer, P.B. Nunn, J. Hugon, A.C. Ludolph, S.M. Ross, D.N. Roy, and R.C. Robertson, Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin, Science 237:517 (1987).
J.D. Rothstein, L. Jin, M. Dykes-Hoberg, and R.W. Kuncl, Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity, Proc. Natl. Acad. Sci. USA 90:6591 (1993).
D.R. Rosen, T. Siddique, D. Patterson, et al., Mutations in Cu/Zn superoxide dismutase genes are associated with familial amyotrophic lateral sclerosis, Nature 362:59 (1993).
D. Choi, Cerebral hypoxia: some new approaches and unanswered questions, J. Neurosci. 10:2493 (1990).
W. Pulsinelli, Pathophysiology of acute ischaemic stroke, Lancet 339:533 (1992).
B. Peruche and J. Krieglstein, Mechanisms of drug actions against neuronal damage caused by ischemia — An overview, Prog. Neuropsychopharmacol. Biol. Psychiat. 17:21 (1993).
J.M. Braughler and E.D. Hall, Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation, Free Radical Biol. Med. 6:289 (1989).
R.A. Floyd, Role of oxygen free radicals in carcinogenesis and brain ischemia, Faseb J. 4:2587 (1990).
J.R. Traystman, J.R. Kirsch, and R.C. Koehler, Oxygen radical mechanisms of brain injury following ischemia and reperfusion, J. Appl. Physiol. 71:1185 (1991).
H. Benveniste, J. Drejer, A. Schousboe, and N. Diemer, Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis, J. Neurochem. 43:1369 (1984).
M.J. Sheardown, E.O. Nielsen, A.J. Hansen, P. Jacobsen, and T. Honoré, 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo (F)quinoxaline: a neuroprotectant for cerebral ischemia, Science 247:571 (1990).
A.M. Buchan, H. Li, and W. Pulsinelli, The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats, J. Neurosci. 11:1049 (1991).
D.K.J.E. Von Lubitz, R.C.-S. Lin, R.J. McKenzie, T.M. Devlin, R.T. McCabe, and P. Skolnick, A novel treatment of global cerebral ischemia with a glycine partial agonist, Europ. J. Pharmacol. 219:153 (1992).
C.N. Oliver, P.E. Starke-Reed, E.R. Stadtman, G.J. Liu, J.M. Carney, and R.A. Floyd, Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain, Proc. Natl. Acad. Sci. USA 87:5144 (1990).
A. Sakamoto, S.T. Ohnishi, T. Ohnishi, and R. Ogawa, Relationship between free radical production and lipis peroxidation during ischemia-reperfusion injury in the rat brain, Brain Res. 554:186 (1991).
H. Hara, K. Kogure, H. Kato, A. Ozaki, and T. Sukamoto, Amelioration of brain damage after focal ischemia in the rat by a novel inhibitor of lipid peroxidation, Europ. J. Pharmacol. 197:75 (1991).
E.D. Hall, K.E. Pazara, and J.M. Braughler, 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils, Stroke 19:997 (1988).
C. Clough-Helfman and J.W. Phillis, The free radical trapping agent N-tert-butyl-α-phenylnitrone (PBN) attenuates cerebral ischaemic injury in gerbils, Free Radical Res. Commun. 15:177 (1991).
S. Imaizumi, V. Woolworth, R.A. Fishman, and P.H. Chan, Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats, Stroke 21:1312 (1990).
H. Kinouchi, C.J. Epstein, T. Mizui, E. Carlson, S.F. Chen, and P.H. Chan, Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase, Proc. Natl. Acad. Sci. USA 88:11158 (1991).
D.E. Pellegrini-Giampietro, R.S. Zukin, M.V.L. Bennett, S. Cho, and W.A. Pulsinelli, Switch in glutamate receptor subunit gene expression in CAI subfield of hippocampus following global ischemia in rats, Proc. Natl. Acad. Sci. USA 89:10499 (1992).
W.A. Pulsinelli, J.B. Brierley, and F. Plum, Temporal profile of neuronal damage in a model of transient forebrain ischemia, Ann. Neurol. 11:491 (1982).
J.K. Deshpande, B.K. Siesjö, and T. Wieloch, Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia, J. Cereb. Blood Flow Metabol. 7:89 (1987).
S.M. Oh and A.L. Betz, Interaction between free radicals and excitatory amino acids in the formation of ischemic brain edema in rats, Stroke 22:915 (1991).
F. Moroni, M. Alesiani, A. Galli, et al., Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptor, Europ. J. Pharmacol. 199:227 (1991).
F. Moroni, M. Alesiani, L. Facci, et al., Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidation, Europ. J. Pharmacol. 218:145 (1992).
J. Chen, S. Graham, F. Moroni, and R. Simon, A study of the dose-dependency of a glycine receptor antagonist in focal ischemia, J. Pharmacol. Exp. Ther. 267:937 (1993).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pellegrini-Giampietro, D.E. (1994). Free Radicals and the Pathogenesis of Neuronal Death: Cooperative Role of Excitatory Amino Acids. In: Armstrong, D. (eds) Free Radicals in Diagnostic Medicine. Advances in Experimental Medicine and Biology, vol 366. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1833-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1833-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5742-1
Online ISBN: 978-1-4615-1833-4
eBook Packages: Springer Book Archive